SCHEMBL7098438

SCHEMBL7098438

COc1cc(Cc2c(N)nc(S)nc2N)cc(OC)c1OC.[KH]

nearest known ligand 0.75

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
DHFR P00374 2/20 0.52
MEN1 O00255 1/20 0.52
SLC22A1 O15245 1/20 0.52
ALDH1A1 P00352 1/20 0.52
CYP3A4 P08684 1/20 0.52
TSHR P16473 1/20 0.52
NFKB1 P19838 1/20 0.52
CYP2C19 P33261 1/20 0.52
BLM P54132 1/20 0.52
KMT2A Q03164 1/20 0.52
HSD17B10 Q99714 1/20 0.52
HTR2A P28223 1/20 0.44
HTR2C P28335 1/20 0.44
HTR2B P41595 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11763535 0.77 DHFR (0.57) DHFRMEN1SLC22A1ALDH1A1CYP3A4
SCHEMBL11821666 0.77 DHFR (0.57) DHFRMEN1SLC22A1ALDH1A1CYP3A4
SCHEMBL7097439 0.75 ALDH1A1 (0.73) DHFRALDH1A1HTR2AHTR2C
SCHEMBL12496384 0.74 HSP90AA1 (0.54) DHFRMEN1SLC22A1ALDH1A1CYP3A4
SCHEMBL7094111 0.73 PNP (0.47) DHFRALDH1A1TSHRHTR2AHTR2C
SCHEMBL8910416 0.72 PTGS2 (0.70) DHFRMEN1SLC22A1ALDH1A1CYP3A4
SCHEMBL7096925 0.71 PNP (0.48) DHFRALDH1A1TSHRHTR2AHTR2C
SCHEMBL18552095 0.71 DHFR (0.65) DHFRMEN1SLC22A1ALDH1A1CYP3A4
SCHEMBL15272016 0.70 DHFR (0.51) DHFRMEN1SLC22A1ALDH1A1CYP3A4
Trimethoprim SCHEMBL2637561 0.69 DHFR (1.00) DHFRMEN1SLC22A1ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1194415-B1 NOVEL PIPERAZINYLALKYLTHIOPYRIMIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND A PROCESS FOR THEIR PREPARATION EGYT GYOGYSZERVEGYESZETI GYAR (HU) 2003-08-20 EP disclosed
US-6469168-B1 FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, ESPECIALLY ANXIETY EGIS Gyógyszergyár Rt. (HU) 2002-10-22 US disclosed